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Background and rationale: Staphylococcus aureus fecal carriage has been identified
as a potential source for nosocomial transmission and a risk factor for disease
development. This systematic review determined the overall S. aureus [including
methicillin susceptible and resistant S. aureus (MSSA and MRSA)] fecal carriage rates
within the community and healthcare settings.
Methodology: Peer-reviewed articles indexed in Medline, Scopus, Academic Search
Premier, Africa-Wide Information, CINAHL, and Web of Science were identified using
applicable and controlled vocabulary through to 11 November 2015. Eligible studies
were ascertained by three independent reviewers. Random-effects meta-analyses of
proportions were performed to determine S. aureus, MSSA and MRSA fecal carriage
rates reported by eligible studies.
Results: Twenty six studies were included in this review. The pooled estimates for
S. aureus, MSSA and MRSA fecal carriage were 26% (95% confidence interval (CI):
16.8–36.3%), 86% (95% confidence interval (CI): 65.9–97.9%) and 10% (95% CI:
0.7–27.0%), respectively. Fecal S. aureus carriage rates increased on average from 10
to 65% during the first 8 weeks of life, followed by an average carriage rate of 64% at 6
months and 46% at 1 year of life. Genotyping techniques were employedmainly in studies
conducted in developed countries and comprised largely of gel-based techniques. Six
studies reported on the role of S. aureus fecal strains in diarrhea (n = 2) and the risk
for acquiring infections (n = 4). Eight of the 26 studies included in this review performed
antibiotic susceptibility testing of S. aureus fecal isolates.
Conclusion: This study provides evidence that screening for S. aureus fecal carriage,
at least in populations at high risk, could be an effective measure for the prevention
of S. aureus transmission and infection in the healthcare and community setting.
More well-structured studies need to be conducted and sequence-based genotyping
techniques should be employed for the comparison of isolates on a global scale in both
developing and developed countries.
Keywords: carriage, community, fecal, Staphylococcus aureus, systematic review
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INTRODUCTION
Staphylococcus aureus is a commensal Gram-positive bacterium,
which under certain circumstances may be responsible for
pyogenic or toxigenic infections, such as skin and soft tissue
infections, toxic shock syndrome and pneumonia (Tong et al.,
2015). Its carriage is considered as an important risk factor for
subsequent development of hospital and community-acquired
infections (Ellis et al., 2004; Wertheim et al., 2004; Maier et al.,
2005; Dukic et al., 2013; Levy et al., 2013). The anterior nares
is recognized as the primary site for S. aureus colonization
(Kluytmans et al., 1997; van Belkum et al., 2009; Sollid et al.,
2014). Other anatomical niches for S. aureus include the skin
(Popov et al., 2014), oropharynx (Mertz et al., 2007; Petersen
et al., 2013), intestinal tract (Acton et al., 2009), and the vagina
(Bourgeois-Nicolaos et al., 2010).
The importance of fecal carriage of S. aureus has been
recognized more than five decades ago in a study which
demonstrated that rectal S. aureus carriage preceded those from
the nose and throat in new-borns (Hurst, 1960). Thereafter,
several studies have provided evidence on the clinical importance
of fecal carriage of S. aureus [in particular methicillin-resistant
S. aureus (MRSA)] in the hospital setting (Acton et al.,
2009). For example, it has been shown that hospitalized
patients with both S. aureus fecal and nasal colonization
are significantly more likely to have positive skin cultures
compared to patients with nasal carriage only (Bhalla et al.,
2007). In addition, S. aureus fecal carriage may serve as
an important source for environmental contamination, which
can potentially facilitate nosocomial transmission within the
healthcare setting (Bhalla et al., 2007). Furthermore, antibiotic-
associated diarrhea attributed to MRSA has also been reported
(Lo and Borchardt, 2009; Sizemore et al., 2012; Avery et al.,
2015); and patients with MRSA colonized diarrheal stools impact
significantly on environmental contamination (Boyce et al.,
2007).
Despite the potential role and significance of the sole fecal
carriage of S. aureus (Lee et al., 1997; Squier et al., 2002; Bhalla
et al., 2007) and the transmission dynamics of S. aureus in
infection, a limited number of studies have focused on fecal S.
aureus carriage in the hospital and community setting (Acton
et al., 2009). This systematic literature review is therefore aimed
to determine the overall rate of S. aureus [including methicillin
susceptible and resistant S. aureus (MSSA and MRSA)] fecal
carriage amongst individuals in the community and healthcare
settings.
TABLE 1 | Search strategy performed in four databases.
Database Search mode Keywords
Medline via Pubmed All fields (“staphylococcus aureus”) AND (“gut” OR “gastrointestinal” OR “anal” OR “anus” OR
“intestinal” OR “rectum” OR “rectal” OR “stool” OR “feces” OR “faeces” OR “fecal”
OR “faecal”) AND (“epidemiology” OR “incidence” OR “prevalence” OR “carriage” OR
“carriage rate” OR carrier*) AND (“humans” OR “human”)
Scopus via SciVerse Article title, abstract, keywords
Academic Search Premier, Africa-Wide
Information and CINAHL via EBSCOHost
Boolean/Phrase
Web of Science via Web of Knowledge Topic
METHODOLOGY
This review followed the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) guidelines (Moher et al.,
2009). The PRISMA check-list for this review is provided in a
Supplementary Table (Table S1).
Literature Search Strategy
Peer-reviewed articles (written in English and French) published
through to 11 November 2015 on S. aureus fecal carriage
within the community and healthcare settings were evaluated
using four electronic databases and a combination of keywords
(Table 1). We also explored for additional articles by checking
the references cited in the primary eligible studies included in this
systematic review.
Study Selection and Data Extraction
Potentially relevant articles (selected based on their titles
and abstracts) were assessed for eligibility (Table 2) by
three independent authors. All potentially eligible articles
were screened for “predatory journals” using “Beall’s list”
(Beall, 2015; Shen and Björk, 2015; Siebert et al., 2015).
The corresponding authors of potentially relevant articles
were contacted to determine the healthcare exposure status
of participants so as to assess their eligibility for inclusion
in this systematic review (Table 2). Data extraction was
performed independently by two authors using a standardized
data extraction form. Disagreements and inconsistencies
were resolved by consensus. The following information was
extracted from each eligible study: study population, number of
participants screened for fecal carriage, participant characteristics
(age, health status, exposure to health care settings), sample
collection details (sample type, age at which samples were
collected, collection site), laboratory techniques (S. aureus and
MRSA screening methods, genotyping techniques, virulence
profile assessment), as well as S. aureus and MRSA detection
rates.
Operational Definitions of Terms Used in
this Systematic Review
Community Setting
Healthy participants
• Participants reported to be healthy at the time of screening
for S. aureus or MRSA fecal carriage without any exposure
to healthcare settings during the year preceding screening
(McKinnell et al., 2013);
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TABLE 2 | Eligibility criteria.
Inclusion criteria for systematic review Exclusion criteria for systematic review
• Studies published from 1920 to 11 November 2015 were included in the
search.
• Studies reporting on S. aureus or MRSA carriage from fecal/rectal/anal
specimens from humans.
• Studies providing information on the prevalence of S. aureus or MRSA fecal
carriage.
• Healthcare exposure data should include information on whether or not
participants were:
1. Hospitalized in the 12 months prior to screening nursing home residents,
health care workers, or patients transferred from other hospitals or wards
(McKinnell et al., 2013).
2. Screened for S. aureus or MRSA fecal carriage within > or < 48 hours of
healthcare contact (Folden et al., 2005; Millar et al., 2007; Otter and French,
2011).
• Studies published in either English or French.
• Studies screening for S. aureus or MRSA from samples other than feces/rectal
swabs/anal swabs.
• Fecal samples studied for parasites or bacteria other than S. aureus.
• Articles reporting on the number of S. aureus or MRSA isolates detected from
fecal specimens or on the number of fecal specimens positive for S. aureus or
MRSA, but not providing information on the number of participants testing
positive for S. aureus or MRSA fecal carriage.
• Studies not providing the necessary healthcare exposure data for participants
(via the published article or via correspondence with the authors), in order to
categorize participants into Healthy participants, Out-patients, In-patients and
Healthcare personnel.
• Articles published in predatory journals (Beall, 2015).
• Articles not obtainable from the electronic databases, the University of Cape
Town (UCT) library or the UCT inter-library loans.
Inclusion criteria for meta-analysis of proportions Exclusion criteria for meta-analysis of proportions
• Overall fecal carriage prevalence for S. aureus and/or MRSA must be available. • Studies providing fecal carriage rates for participants for which fecal carriage
rates have previously been reported.
• Studies not providing information on the age at which participants were
screened.
• Studies screening a pre-selected group of participants based on
microbiological assessments.
• Studies for which MRSA was not confirmed using molecular methods.
• Pregnant women visiting obstetric clinics;
• New-borns and mothers at maternity wards during the time of
delivery;
• Mothers and infants reported as healthy at the time of
screening for S. aureus or MRSA fecal carriage, but exposed to
the delivery unit or maternity ward during the year preceding
screening.
Out-patients
Patients screened for S. aureus or MRSA fecal carriage with ≤48
h of healthcare contact (Folden et al., 2005; Millar et al., 2007;
Otter and French, 2011). Patients should not have had contact
with healthcare settings in the year preceding the study.
Healthcare Setting
In-patients
Patients screened for S. aureus or MRSA fecal carriage with
>48 h of healthcare contact. Patients screened within ≤48
h after admission should be those transferred from another
hospital/ward which will allow for>48 h of hospital contact.
Healthcare personnel
Participants screened for S. aureus or MRSA fecal carriage
working at a healthcare setting with or without any illness.
Developed and Developing Countries
Countries were categorized as developed or developing countries
based on data from the International Monetary Fund (http://
www.imf.org/external/pubs/ft/weo/2015/01/weodata/groups.
htm).
Antibiotic Susceptibility Results
The percentage of isolates (obtained from participants with
S. aureus or MRSA fecal carriage) resistant to each of the
antibiotics assayed was calculated from studies that provided
adequate data on antibiotic susceptibility test results. Our review
noted susceptibility tests results whether or not the respective
studies incorporated published guidelines [such as Clinical
Laboratory Standards Institute (CLSI), National Committee on
Clinical Laboratory Standards (NCCLS), European Committee
on Antimicrobial Susceptibility Testing (EUCAST), Antibiogram
Committee of the French Society of Microbiology (CA-SFM), or
the Swedish Reference Group for Antibiotics (SRGA) guidelines]
in assessing the antibiotic resistance profiles.
Statistical Analysis and Data Visualization
The S. aureus, MRSA and MSSA fecal carriage rates for studies
included in this systematic review were calculated as follows:
S. aureus fecal carriage rate (%) =
Participants positive for S. aureus fecal carriage
Participants screened for S. aureus fecal carriage
MRSA fecal carriage rate (%) =
Participants positive for MRSA fecal carriage
Participants screened for S. aureus or MRSA fecal carriage
MSSA fecal carriage rate (%) =
(Participants positive for S. aureus fecal carriage
- Participants positive for MRSA fecal carriage)
Participants screened for S. aureus fecal carriage
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Individual reports assessing the same participants for S. aureus,
MSSA or MRSA fecal carriage were considered as a single
report. Calculated fecal S. aureus carriage rates were used to
derive longitudinal data of individual studies, as well as the
average carriage rate amongst these studies, at each time-point.
Meta-analyses of proportions were performed to determine
the overall S. aureus, MSSA and MRSA fecal carriage rates
(pooled estimates) among individuals in the community and
healthcare settings. Meta-analyses of proportions for MRSA
and MSSA did not include studies for which MRSA was not
confirmed using molecular methods. For all meta-analyses of
proportions, studies screening for MRSA amongst pre-selected
vancomycin resistant enterococci (VRE) fecal carriers were
excluded. Similarly, meta-analyses of proportions did not include
studies that screened for MRSA fecal carriage solely from pre-
selected MRSA carriers (MRSA identified from other body
sites). Meta-analyses were performed using StatsDirect statistical
software version 3.0.165 [England: StatsDirect Ltd. 2016] for
studies adhering to the inclusion criteria summarized in Table 2.
The StatsDirect statistical software version 3.0.165 [England:
StatsDirect Ltd. 2016] was also applied to assess the heterogeneity
between the studies included in the meta-analyses (Cochran Q-
test) (Cochran, 1954) and to determine the inconsistency across
the studies included (I2 statistic) (Higgins et al., 2003). The
criterion for statistical significance for the test for heterogeneity
was set at alpha = 0.05. The risk of publication bias was assessed
and visualized by a Funnel plot (Egger et al., 1997; Sterne et al.,
2011).
RESULTS
Study Selection and Characteristics
S. aureus Study Selection
Figure 1 outlines the study selection process and the broad
reasons for exclusion. The search strategy identified 2522
records. An additional record was identified from the reference
list of one of the eligible articles included in the review.
A total of 124 potentially eligible reports were identified, of
which 69 fulfilled the primary inclusion criteria (Figure 1).
The vast majority (80%; 55/69) of these potentially eligible
articles did not provide information on healthcare exposure
during the year preceding screening and/or did not indicate
the duration for which patients were admitted prior to the
time of screening. Following correspondence with authors,
seven articles were excluded as these reports did not fulfill our
inclusion criteria. Moreover, 36 articles were excluded due to
lack of required information from corresponding authors or as a
result of unavailable author contact information. Consequently,
only 26 (11 and 15 reports based on their full texts and
information obtained from the authors, respectively) of the
69 studies could be included in our systematic review. The
main findings reported by each of the 26 eligible studies
are summarized in detail in Tables 3, 4. Select studies that
screened for S. aureus fecal carriage from both community
and healthcare settings are also reported accordingly in
Tables 3, 4.
Characteristics of Reports from Community and
Healthcare Settings
Reports on S. aureus fecal carriage
A total of 19 reports investigated fecal S. aureus carriage within
the community setting, of which five and 14 studies reported
on fecal carriage rates from outpatients and healthy participants,
respectively (Table 3). Moreover, the majority (64%; 9/14) of
reports on fecal S. aureus carriage rates from healthy participants
were of longitudinal design and investigated infants up until
one year of age (Table 3). Of the five reports on fecal carriage
rates from outpatients, a single study performed a longitudinal
analysis of S. aureus fecal carriage (Efuntoye and Adetosoye,
2003) and another investigated infants during the first year of
life (Shehabi et al., 2013). Study sizes for the community setting
ranged between 21 and 1761 participants (Table 3).
Fecal S. aureus carriage within the healthcare setting was
noted in 12 reports (Table 4). Of these, 10 were from inpatients
and two from healthcare personnel. All reports on inpatients
were of cross-sectional design and the majority (60%; 6/10)
did not provide information on the age of the participants. In
addition, the two studies on healthcare personnel were cross-
sectional in design and carried out in the United States of
America (USA) (Carmeli et al., 1998; Andrews et al., 2009). Study
sizes for healthcare-based reports ranged between 37 and 2727
participants (Table 4).
Reports on methicillin susceptible and resistant S. aureus
fecal carriage
Six of the 19 reports on S. aureus fecal carriage from
the community setting provided MRSA fecal carriage rates
confirmed by molecular methods (Table 3). Five of these studies
(conducted in developed countries) reported both S. aureus and
MRSA fecal carriage rates which allowed for the calculation of
MSSA fecal carriage rates. Only one study within the healthcare
setting (conducted in the USA) confirmed fecal MRSA carriage
by screening specimens using a molecular approach (Andrews
et al., 2009).
Pooled Estimates of S. aureus Fecal
Carriage Rates Assessed by
Meta-Analyses
Studies included in all of the proportional meta-analyses were
heterogeneous, as determined by the Cochrane Q test and I2
statistic (Figures 2–4). We could not determine pooled MSSA or
MRSA fecal carriage rates within the healthcare setting as only a
single study was considered eligible for this analysis.
The pooled random-effects estimate for S. aureus fecal
carriage within the community and healthcare settings was 26%
(95% CI = 16.8–36.3; Figure 5). Sub-analyses of S. aureus fecal
carriage within the community and healthcare settings resulted
in pooled random-effects estimates of 31% (95% CI = 17.8–46.3)
and 5% (95% CI= 1.7–8.9), respectively.
MSSA fecal carriage was estimated at 86% (95% CI = 65.9–
97.9) using the random-effects model (Figure 6). Within the
community setting, the random effects estimate for MSSA fecal
Frontiers in Microbiology | www.frontiersin.org 4 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
FIGURE 1 | Study selection. Flow diagram of identification and selection process for studies included in the systematic review.
carriage was 86% (95% CI = 62.3–98.5). The pooled random-
effects estimates for MRSA fecal carriage were 10% (95% CI =
0.7–27.0; Figure 7); and 10% (95% CI = 0.4–28.9) within the
community setting.
S. aureus Fecal Carriage Rates According
to the Age of Participants
The report on this section is not based on meta-analysis. S.
aureus fecal carriage rates within the community setting were
higher during the first year of life (Figure 8). On average, reports
from longitudinal studies revealed an increase in S. aureus fecal
carriage rates from approximately 10–65% during the first 8
weeks of life (Figure 8). At 6 months of age, the average fecal
carriage rate was 64%, thereafter it decreased to approximately
46% at 1 year of life. A longitudinal investigation of fecal MRSA
carriage rates from healthy participants from the USA showed an
increase in fecal MRSA carriage from 0 to 9% during the first 2
weeks of life (Gries et al., 2009). The highest MRSA fecal carriage
rate (23%) reported was from Spanish infants screened at≤1 year
of life (Benito et al., 2015).
Assessment of Antibiotic Susceptibility of
Fecal S. aureus Isolates
Eight of the 26 eligible studies (31%) included in this review
assayed for antibiotic susceptibility of fecal S. aureus or MRSA
isolates (Table 5). Overall, S. aureus or MRSA isolates were
Frontiers in Microbiology | www.frontiersin.org 5 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
3
|
C
h
a
ra
c
te
ri
s
ti
c
s
o
f
e
li
g
ib
le
s
tu
d
ie
s
a
n
a
ly
s
in
g
fe
c
a
l
c
a
rr
ia
g
e
o
f
S
ta
p
h
y
lo
c
o
c
c
u
s
a
u
re
u
s
o
r
M
R
S
A
fr
o
m
th
e
c
o
m
m
u
n
it
y.
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
s
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
C
A
T
E
G
O
R
Y
:
H
E
A
LT
H
Y
P
A
R
T
IC
IP
A
N
T
S
It
a
ly
1
0
0
B
irt
h
to
1
2
m
o
n
th
s
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
R
e
c
ta
l
sw
a
b
s
3
d
a
ys
D
e
liv
e
ry
u
n
it
P
h
e
n
o
ty
p
ic
N
P
R
A
P
D
S
E
T
S
S
T
5
(5
/1
0
0
)ϕ
N
A
L
in
d
b
e
rg
e
t
a
l.,
2
0
1
0
F
e
c
e
s
1
w
e
e
k
H
o
m
e
1
5
(1
5
/1
0
0
)ϕ
2
w
e
e
ks
2
4
(2
4
/1
0
0
)ϕ
4
w
e
e
ks
3
4
(3
4
/1
0
0
)ϕ
8
w
e
e
ks
4
5
(4
5
/1
0
0
)ϕ
6
m
o
n
th
s
5
2
(5
2
/1
0
0
)ϕ
1
ye
a
r
3
1
(2
7
/8
6
)ϕ
O
ve
ra
ll
p
re
va
le
n
c
e
6
6
(6
6
/1
0
0
)ϕ
M
o
za
m
b
iq
u
e
1
2
1
≤
1
4
d
a
ys
to
1
ye
a
r
A
p
p
a
re
n
tly
h
e
a
lth
y
N
R
F
e
c
e
s
≤
1
4
d
a
ys
to
1
ye
a
r
H
o
m
e
M
o
le
c
u
la
r
N
P
N
P
N
P
7
7
(9
2
/1
2
0
)
N
A
G
o
n
zá
le
z
e
t
a
l.,
2
0
1
3
N
ig
e
ria
1
2
0
1
5
–3
5
ye
a
rs
H
e
a
lth
y
N
o
F
e
c
e
s
1
5
to
3
5
ye
a
rs
P
ro
vi
d
e
d
b
y
p
a
rt
ic
ip
a
n
ts
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
N
P
N
P
3
2
(3
8
/1
2
0
)
3
4
(1
3
/3
8
)¶
O
n
a
n
u
g
a
a
n
d
Te
m
e
d
ie
,
2
0
1
1
S
p
a
in
2
1
7
–3
5
d
a
ys
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
ϕ
F
e
c
e
s
1
w
e
e
k
H
o
m
e
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
s
p
a
ty
p
in
g
S
E
1
0
(2
/2
1
)
1
4
(3
/2
1
)
B
e
n
ito
e
t
a
l.,
2
0
1
5
2
w
e
e
ks
a
g
r
ty
p
in
g
P
V
L
5
w
e
e
ks
M
L
S
T
E
T
4
8
(1
0
/2
1
)
O
ve
ra
ll
p
re
va
le
n
c
e
P
F
G
E
T
S
S
T
5
7
(1
2
/2
1
)
4
2
(5
/1
2
)
A
U
R
B
A
P
C
N
A
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
3
|
C
o
n
ti
n
u
e
d
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
s
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
S
p
a
in
1
0
0
2
–8
9
ye
a
rs
H
e
a
lth
y
N
o
ϕ
F
e
c
e
s
2
–8
9
ye
a
rs
N
R
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
s
p
a
ty
p
in
g
S
E
1
5
(1
5
/1
0
0
)
0
(0
/1
5
)
B
e
n
ito
e
t
a
l.,
2
0
1
3
a
g
r
ty
p
in
g
P
V
L
M
L
S
T
E
T
T
S
S
T
A
U
R
B
A
P
C
N
A
S
p
a
in
5
0
7
–2
3
m
o
n
th
s
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
ϕ
F
e
c
e
s
7
–2
3
m
o
n
th
s
N
u
rs
e
rie
s
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
N
P
N
P
6
(3
/5
0
)
0
(0
/3
)
D
o
m
ín
g
u
e
z
e
t
a
l.,
2
0
0
2
S
w
e
d
e
n
1
0
0
B
irt
h
to
1
2
m
o
n
th
s
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
R
e
c
ta
l
sw
a
b
s
F
e
c
e
s
3
d
a
ys
D
e
liv
e
ry
u
n
it
P
h
e
n
o
ty
p
ic
N
P
R
A
P
D
S
E
T
S
S
T
1
6
(1
6
/1
0
0
)ϕ
N
A
L
in
d
b
e
rg
e
t
a
l.,
2
0
1
0
1
w
e
e
k
H
o
m
e
4
8
(4
8
/1
0
0
)ϕ
2
w
e
e
ks
5
6
(5
6
/1
0
0
)ϕ
4
w
e
e
ks
6
4
(6
4
/1
0
0
)ϕ
8
w
e
e
ks
7
2
(7
2
/1
0
0
)ϕ
6
m
o
n
th
s
6
8
(6
8
/1
0
0
)ϕ
1
ye
a
r
5
5
(5
5
/1
0
0
)ϕ
O
ve
ra
ll
p
re
va
le
n
c
e
7
8
(7
8
/1
0
0
)ϕ
S
w
e
d
e
n
6
4
B
irt
h
to
8
w
e
e
ks
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
R
e
c
ta
l
sw
a
b
s
3
d
a
ys
ϕ
D
e
liv
e
ry
u
n
itϕ
P
h
e
n
o
ty
p
ic
N
P
N
P
S
E
T
S
S
T
1
3
(8
/6
4
)ϕ
N
A
L
u
n
d
e
ll
e
t
a
l.,
2
0
0
9
F
e
c
e
s
1
w
e
e
k
H
o
m
e
ϕ
3
9
(2
5
/6
4
)ϕ
2
w
e
e
ks
5
3
(3
3
/6
2
)ϕ
4
w
e
e
ks
5
9
(3
7
/6
3
)ϕ
8
w
e
e
ks
7
1
(4
4
/6
2
)ϕ
O
ve
ra
ll
p
re
va
le
n
c
e
7
3
(4
7
/6
4
)ϕ
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 7 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
3
|
C
o
n
ti
n
u
e
d
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
s
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
S
w
e
d
e
n
5
0
B
irt
h
to
1
2
m
o
n
th
s
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
R
e
c
ta
l
sw
a
b
s
3
d
a
ys
D
e
liv
e
ry
u
n
it
P
h
e
n
o
ty
p
ic
N
P
R
A
P
D
P
F
G
E
E
T
T
S
S
T
2
0
(1
0
/5
0
)
N
A
L
in
d
b
e
rg
e
t
a
l.,
2
0
0
4
a
1
w
e
e
k
H
o
m
e
4
0
(2
0
/5
0
)
2
w
e
e
ks
5
2
(2
6
/5
0
)
4
w
e
e
ks
6
0
(3
0
/5
0
)
8
w
e
e
ks
6
4
(3
2
/5
0
)
O
ve
ra
ll
p
re
va
le
n
c
e
6
8
(3
4
/5
0
)
3
7
A
p
p
a
re
n
tly
h
e
a
lth
yϕ
A
lle
rg
ic
a
n
d
n
o
n
-
a
lle
rg
ic
m
o
th
e
rs
A
t
tim
e
o
f
d
e
liv
e
ry
F
e
c
e
s
1
w
e
e
k
a
ft
e
r
d
e
liv
e
ry
o
r
a
t
a
la
te
r
st
a
g
e
H
o
m
e
2
4
(9
/3
7
)
N
A
S
w
e
d
e
n
8
1
B
irt
h
to
1
2
m
o
n
th
s
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
R
e
c
ta
l
sw
a
b
s
3
d
a
ys
D
e
liv
e
ry
u
n
it
a
t
3
d
a
ys
a
n
d
h
o
m
e
a
t
1
w
e
e
k
to
1
ye
a
r
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
R
A
P
D
E
T
T
S
S
T
N
R
0
(0
/8
1
)ϕ
L
in
d
b
e
rg
e
t
a
l.,
2
0
0
4
b
1
w
e
e
k
2
w
e
e
ks
4
w
e
e
ks
8
w
e
e
ks
6
m
o
n
th
s
1
ye
a
r
S
w
e
d
e
n
4
9
B
irt
h
to
1
2
m
o
n
th
s
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
R
e
c
ta
l
sw
a
b
s
3
d
a
ys
D
e
liv
e
ry
u
n
it
P
h
e
n
o
ty
p
ic
N
P
R
A
P
D
E
T
T
S
S
T
1
6
(8
/4
9
)
N
A
L
in
d
b
e
rg
e
t
a
l.,
2
0
0
0
F
e
c
e
s
1
w
e
e
k
H
o
m
e
5
7
(2
8
/4
9
)
2
w
e
e
ks
6
5
(3
2
/4
9
)
4
w
e
e
ks
6
5
(3
2
/4
9
)
8
w
e
e
ks
7
3
(3
6
/4
9
)
6
m
o
n
th
s
7
3
(3
6
/4
9
)
1
ye
a
r
5
3
(2
6
/4
9
)
O
ve
ra
ll
p
re
va
le
n
c
e
8
6
(4
2
/4
9
)ϕ
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 8 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
3
|
C
o
n
ti
n
u
e
d
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
s
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
U
n
ite
d
K
in
g
d
o
m
3
0
2
–7
m
o
n
th
s
H
e
a
lth
y
N
R
F
e
c
e
s
2
w
e
e
ks
H
o
m
e
P
h
e
n
o
ty
p
ic
N
P
N
P
S
E
T
S
S
T
3
7
(1
1
/3
0
)
N
A
H
a
rr
is
o
n
e
t
a
l.,
2
0
0
9
1
0
w
e
e
ks
4
0
(1
2
/3
0
)
7
m
o
n
th
s
4
0
(1
2
/3
0
)
O
ve
ra
ll
p
re
va
le
n
c
e
4
0
(1
2
/3
0
)
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ric
a
1
4
7
>
1
8
ye
a
rs
H
e
a
lth
y
p
re
g
n
a
n
t
w
o
m
e
n
a
t
3
5
-3
7
w
e
e
ks
o
f
p
re
g
n
a
n
c
y
N
o
ϕ
R
e
c
ta
l
sw
a
b
s
>
1
8
ye
a
rs
O
b
st
e
tr
ic
c
lin
ic
s
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
S
C
C
m
e
c
ty
p
in
g
P
F
G
E
P
V
L
4
(6
/1
4
7
)ϕ
0
(0
/6
)ϕ
A
n
d
re
w
s
e
t
a
l.,
2
0
0
9
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ric
a
3
8
1
d
a
y
to
2
w
e
e
ks
H
e
a
lth
y
A
t
tim
e
o
f
d
e
liv
e
ry
F
e
c
e
s
1
–2
d
a
ys
N
e
w
-b
o
rn
u
n
it
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
F
G
E
P
V
L
0
(0
/3
8
)
0
(0
/3
8
)
G
rie
s
e
t
a
l.,
2
0
0
9
2
w
e
e
ks
2
6
(6
/2
3
)
3
3
(2
/6
)
O
ve
ra
ll
p
re
va
le
n
c
e
2
6
(6
/2
3
)
3
3
(2
/6
)
C
A
T
E
G
O
R
Y
:
O
U
T
P
A
T
IE
N
T
S
In
d
ia
1
0
0
1
6
–8
8
ye
a
rs
P
a
tie
n
ts
a
t
a
d
m
is
si
o
n
N
o
lo
n
g
h
o
sp
ita
l
st
a
y
o
r
a
d
m
is
si
o
n
to
o
th
e
r
h
o
sp
ita
ls
F
e
c
e
s
1
6
–8
8
ye
a
rs
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
N
P
N
P
N
P
0
(0
/1
0
0
)
N
A
D
e
e
p
a
e
t
a
l.,
2
0
1
4
Jo
rd
a
n
2
1
6
≤
2
8
d
a
ys
to
1
ye
a
r
N
R
N
o
F
e
c
e
s
<
2
8
d
a
ys
to
1
ye
a
r
C
lin
ic
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
S
C
C
m
e
c
ty
p
in
g
E
T
1
7
(3
7
/2
1
6
)
5
9
(2
2
/3
7
)
S
h
e
h
a
b
i
e
t
a
l.,
2
0
1
3
P
V
L
S
E
T
S
S
T
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 9 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
3
|
C
o
n
ti
n
u
e
d
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
s
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
N
ig
e
ria
1
7
6
1
≤
5
ye
a
rs
D
ia
rr
h
o
e
ic
c
h
ild
re
n
N
o
ϕ
F
e
c
e
s
<
1
ye
a
r
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
N
P
E
T
3
(1
1
/4
1
6
)
N
R
E
fu
n
to
ye
a
n
d
A
d
e
to
so
ye
,
2
0
0
3
1
.1
–2
.0
ye
a
rs
4
(1
3
/3
2
3
)
N
R
2
.1
–3
.0
ye
a
rs
4
(1
2
/3
0
9
)
N
R
3
.1
–4
.0
ye
a
rs
5
(1
5
/2
9
2
)
N
R
4
.1
–5
.0
ye
a
rs
5
(2
1
/4
2
1
)
N
R
O
ve
ra
ll
p
re
va
le
n
c
e
4
(7
2
/1
7
6
1
)
N
R
S
a
u
d
iA
ra
b
ia
5
8
N
R
P
a
tie
n
ts
a
t
a
d
m
is
si
o
n
(<
4
8
h
)ϕ
w
ith
d
ia
rr
h
e
a
o
r
a
b
d
o
m
in
a
l
p
a
in
N
o
ϕ
F
e
c
e
s
N
R
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
N
P
N
P
N
A
9
(5
/5
8
)
B
a
b
a
y
a
n
d
S
o
m
ily
,
2
0
0
9
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ric
a
1
5
0
B
irt
h
to
1
8
ye
a
rs
C
h
ild
re
n
re
q
u
iri
n
g
a
b
sc
e
ss
d
ra
in
a
g
e
(n
=
6
0
)
N
o
ϕ
R
e
c
ta
l
sw
a
b
s
B
irt
h
to
1
8
ye
a
rs
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
M
o
le
c
u
la
r
M
LV
A
S
C
C
m
e
c
ty
p
in
g
P
V
L
4
7
(2
8
/6
0
)
N
R
F
a
d
e
n
e
t
a
l.,
2
0
1
0
C
h
ild
re
n
re
q
u
iri
n
g
g
e
n
e
ra
l
su
rg
e
ry
(n
=
9
0
)
1
(1
/9
0
)
N
R
9
F
e
c
a
ls
a
m
p
le
s
,
re
c
ta
ls
w
a
b
s
,
a
n
a
ls
w
a
b
s
,
p
e
ri
-r
e
c
ta
lo
r
p
e
ri
-a
n
a
ls
w
a
b
s
.
†
H
o
s
p
it
a
l,
lo
n
g
-t
e
rm
c
a
re
fa
c
ili
ty
,
n
u
rs
in
g
h
o
m
e
s
,
m
a
te
rn
it
y
w
a
rd
s
.
¶ R
e
s
is
ta
n
t
to
c
e
fo
xi
ti
n
.
ϕ
In
fo
rm
a
ti
o
n
o
b
ta
in
e
d
fr
o
m
th
e
a
u
th
o
r.
P
h
e
n
o
ty
p
ic
id
e
n
ti
fic
a
ti
o
n
:
c
u
lt
u
re
c
h
a
ra
c
te
ri
s
ti
c
s
o
n
m
a
n
n
it
o
ls
a
lt
a
g
a
r,
B
a
ir
d
-P
a
rk
e
r
a
g
a
r,
Tr
ip
ti
c
a
s
e
s
o
y
a
g
a
r,
C
h
a
p
m
a
n
a
g
a
r,
S
ta
p
h
yl
o
c
o
c
c
u
s
m
e
d
iu
m
1
1
0
,
p
o
s
it
iv
e
re
s
u
lt
s
fo
r
G
ra
m
s
ta
in
,
c
a
ta
la
s
e
,
c
o
a
g
u
la
s
e
a
n
d
D
N
a
s
e
Te
s
ts
.
a
g
r,
A
c
c
e
s
s
o
ry
g
e
n
e
re
g
u
la
to
r;
A
U
R
,
A
u
re
o
ly
s
is
n
;
B
A
P,
b
io
fil
m
-a
s
s
o
c
ia
te
d
p
ro
te
in
;
C
A
N
,
c
o
lla
g
e
n
-b
in
d
in
g
p
ro
te
in
;
E
T,
E
xf
o
lia
ti
ve
to
xi
n
s
;
M
LV
A
,
M
u
lt
ip
le
-l
o
c
u
s
va
ri
a
b
le
-n
u
m
b
e
r
ta
n
d
e
m
re
p
e
a
t
a
n
a
ly
s
is
;
M
R
S
A
,
m
e
th
ic
ill
in
re
s
is
ta
n
t
S
ta
p
h
yl
o
c
o
c
c
u
s
a
u
re
u
s
;
N
R
,
N
o
t
re
p
o
rt
e
d
;
N
P,
N
o
t
p
e
rf
o
rm
e
d
;
N
A
,
N
o
t
a
p
p
lic
a
b
le
;
P
F
G
E
,
p
u
ls
e
d
-fi
e
ld
g
e
l
e
le
c
tr
o
p
h
o
re
s
is
;
P
V
L
,
P
a
n
to
n
-V
a
le
n
ti
n
e
L
e
u
ko
c
id
in
;
R
A
P
D
,
ra
n
d
o
m
a
m
p
lifi
e
d
p
o
ly
m
o
rp
h
ic
D
N
A
;
S
C
C
m
e
c
,
s
ta
p
h
yl
o
c
o
c
c
a
l
c
a
s
s
e
tt
e
c
h
ro
m
o
s
o
m
e
m
e
c
;
S
E
,
S
ta
p
h
yl
o
c
o
c
c
a
l
e
n
te
ro
to
xi
n
s
;
s
p
a
,
S
ta
p
h
yl
o
c
o
c
c
u
s
a
u
re
u
s
p
ro
te
in
A
;
T
S
S
T,
To
xi
c
s
h
o
c
k
s
yn
d
ro
m
e
to
xi
n
.
Frontiers in Microbiology | www.frontiersin.org 10 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
4
|
C
h
a
ra
c
te
ri
s
ti
c
s
o
f
e
li
g
ib
le
s
tu
d
ie
s
a
n
a
ly
s
in
g
fe
c
a
l
c
a
rr
ia
g
e
o
f
S
ta
p
h
y
lo
c
o
c
c
u
s
a
u
re
u
s
o
r
M
R
S
A
fr
o
m
th
e
h
e
a
lt
h
c
a
re
s
e
tt
in
g
.
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
C
A
T
E
G
O
R
Y
:
IN
-P
A
T
IE
N
T
S
F
ra
n
c
e
7
4
8
M
e
a
n
a
g
e
:
5
5
ye
a
rs
±
1
2
L
iv
e
r
c
ir
rh
o
si
s
H
o
sp
ita
liz
e
d
fo
r
m
in
im
u
m
o
f
2
w
e
e
k
s
F
e
c
e
s
M
e
a
n
a
g
e
:
5
5
ye
a
rs
±
1
2
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
N
P
N
P
N
R
1
2
(9
3
/7
4
8
)
C
a
m
p
ill
o
e
t
a
l.,
2
0
0
1
F
ra
n
c
e
3
2
7
N
R
C
h
ro
n
ic
liv
e
r
d
is
e
a
se
,
p
o
st
-s
u
rg
ic
a
l
p
a
tie
n
ts
,
p
a
tie
n
ts
w
ith
a
lc
o
h
o
l
w
ith
d
ra
w
a
la
n
d
d
ig
e
st
iv
e
tr
a
c
t
d
is
e
a
se
s
P
a
tie
n
ts
tr
a
n
sf
e
rr
e
d
fr
o
m
o
th
e
r
h
o
sp
ita
ls
F
e
c
e
s
N
R
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
h
e
n
o
ty
p
ic
P
F
G
E
N
P
N
R
1
1
(3
6
/3
2
7
)
D
u
p
e
yr
o
n
e
t
a
l.,
2
0
0
2
G
e
rm
a
n
y
2
7
2
7
N
R
N
o
so
c
o
m
ia
l
d
ia
rr
h
e
a
≥
7
2
h
a
t
th
e
tim
e
o
f
st
u
d
y
F
e
c
e
s
N
R
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
N
P
S
E
7
(1
9
8
/2
7
2
7
)
1
5
(2
9
/1
9
8
)
F
le
m
m
in
g
a
n
d
A
c
k
e
rm
a
n
n
,
2
0
0
7
G
e
rm
a
n
y
1
3
1
N
R
N
R
In
p
a
tie
n
ts
p
o
si
tiv
e
fo
r
M
R
S
A
R
e
c
ta
ls
w
a
b
s
N
R
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
F
G
E
S
E
N
R
4
7
(6
1
/1
3
1
)
K
lo
tz
e
t
a
l.,
2
0
0
5
J
o
rd
a
n
2
1
4
≤
2
8
d
a
ys
to
1
ye
a
r
N
R
N
R
F
e
c
e
s
≤
2
8
d
a
ys
to
1
ye
a
r
N
IC
U
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
S
C
C
m
e
c
ty
p
in
g
E
T
2
(5
/2
1
4
)
2
0
(1
/5
)
S
h
e
h
a
b
ie
t
a
l.,
2
0
1
3
P
V
L
S
E
T
S
S
T
S
a
u
d
iA
ra
b
ia
1
2
2
N
R
N
R
≥
7
2
h
a
t
th
e
tim
e
o
f
st
u
d
y
F
e
c
e
s
N
R
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
N
P
N
P
N
A
7
(9
/1
2
2
)
B
a
b
a
y
a
n
d
S
o
m
ily
,
2
0
0
9
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ri
c
a
8
1
0
(2
0
0
0
-0
1
)N
R
C
a
n
c
e
r
In
p
a
tie
n
ts
ϕ
R
e
c
ta
ls
w
a
b
s
N
R
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
P
h
e
n
o
ty
p
ic
s
p
a
ty
p
in
g
P
V
L
N
R
0
.6
(5
/8
1
0
)ϕ
S
ri
n
iv
a
sa
n
e
t
a
l.,
2
0
1
0
M
L
S
T
9
2
5
(2
0
0
6
-0
7
)
P
F
G
E
2
.9
(2
7
/9
2
5
)ϕ
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
T
A
B
L
E
4
|
C
o
n
ti
n
u
e
d
S
tu
d
y
p
o
p
u
la
ti
o
n
s
e
tt
in
g
P
a
rt
ic
ip
a
n
ts
s
c
re
e
n
e
d
fo
r
fe
c
a
l9
c
a
rr
ia
g
e
(n
)
P
a
rt
ic
ip
a
n
t
c
h
a
ra
c
te
ri
s
ti
c
s
S
a
m
p
le
c
o
ll
e
c
ti
o
n
L
a
b
o
ra
to
ry
te
c
h
n
iq
u
e
(s
)
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
R
e
fe
re
n
c
e
A
g
e
ra
n
g
e
H
e
a
lt
h
s
ta
tu
s
E
x
p
o
s
u
re
to
h
e
a
lt
h
c
a
re
s
e
tt
in
g
1
2
m
o
n
th
s
p
ri
o
r
to
s
c
re
e
n
in
g
†
S
a
m
p
le
ty
p
e
A
g
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
it
e
a
t
w
h
ic
h
s
a
m
p
le
s
w
e
re
c
o
ll
e
c
te
d
S
.
a
u
re
u
s
d
e
te
c
ti
o
n
M
R
S
A
d
e
te
c
ti
o
n
G
e
n
o
ty
p
in
g
V
ir
u
le
n
c
e
p
ro
fi
le
a
n
a
ly
s
is
%
(n
/N
)
&
(n
/N
)
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ri
c
a
1
6
1
5
7
–
1
0
3
ye
a
rs
F
e
c
a
la
n
d
u
ri
n
a
ry
in
-c
o
n
tin
e
n
c
e
,
p
re
ss
u
re
u
lc
e
rs
,
d
ia
b
e
te
s,
C
O
P
D
,
h
e
a
rt
fa
ilu
re
L
o
n
g
-t
e
rm
c
a
re
fa
c
ili
ty
re
si
d
e
n
ts
R
e
c
ta
ls
w
a
b
s
5
7
-1
0
3
ye
a
rs
L
o
n
g
-t
e
rm
c
a
re
w
a
rd
s
N
P
P
h
e
n
o
ty
p
ic
P
F
G
E
N
P
N
A
3
(4
/1
6
1
)
O
’F
a
llo
n
e
t
a
l.,
2
0
0
9
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ri
c
a
3
7
4
8
–
9
1
ye
a
rs
C
h
ro
n
ic
re
n
a
lf
a
ilu
re
,
d
ia
b
e
te
s,
c
h
ro
n
ic
d
e
rm
a
to
-l
o
g
ic
in
fe
c
tio
n
s
In
p
a
tie
n
ts
p
o
si
tiv
e
fo
r
V
R
E
F
e
c
e
s
4
8
to
9
1
ye
a
rs
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
P
F
G
E
N
P
6
2
(2
3
/3
7
)
8
7
(2
0
/2
3
)
R
a
y
e
t
a
l.,
2
0
0
3
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ri
c
a
1
1
4
N
R
N
R
S
k
ill
e
d
-c
a
re
p
a
tie
n
ts
a
d
m
itt
e
d
fo
r
lo
n
g
-t
e
rm
c
a
re
R
e
c
ta
ls
w
a
b
s
H
o
sp
ita
l
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
P
F
G
E
N
P
N
R
5
(6
/1
1
4
)
Tr
ic
k
e
t
a
l.,
2
0
0
1
C
A
T
E
G
O
R
Y
:
H
E
A
LT
H
C
A
R
E
P
E
R
S
O
N
N
E
L
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ri
c
a
6
2
>
1
8
ye
a
rs
H
e
a
lth
y
p
re
g
n
a
n
t
w
o
m
e
n
a
t
3
5
–
3
7
w
e
e
k
s
o
f
p
re
g
n
a
n
c
y
N
o
ϕ
R
e
c
ta
ls
w
a
b
s
>
1
8
ye
a
rs
O
b
st
e
tr
ic
c
lin
ic
s
P
h
e
n
o
ty
p
ic
P
h
e
n
o
ty
p
ic
a
n
d
M
o
le
c
u
la
r
S
C
C
m
e
c
ty
p
in
g
P
V
L
3
(2
/6
2
)ϕ
0
(0
/2
)ϕ
A
n
d
re
w
s
e
t
a
l.,
2
0
0
9
P
F
G
E
U
n
ite
d
S
ta
te
s
o
f
A
m
e
ri
c
a
5
5
3
6
ye
a
rs
±
1
1
N
R
N
u
rs
e
s
(n
=
2
9
),
P
h
ys
ic
ia
n
s
(n
=
1
5
),
O
th
e
rs
(n
=
9
),
U
n
k
n
o
w
n
(n
=
2
)
(m
e
a
n
p
a
tie
n
t
c
o
n
ta
c
t
ye
a
rs
:
1
3
ye
a
rs
±
9
)
F
e
c
a
l
3
6
ye
a
rs
±
1
1
N
R
N
P
P
h
e
n
o
ty
p
ic
N
P
N
P
N
A
0
(0
/5
5
)
C
a
rm
e
li
e
t
a
l.,
1
9
9
8
9
F
e
c
a
ls
a
m
p
le
s
,
re
c
ta
ls
w
a
b
s
,
a
n
a
ls
w
a
b
s
,
p
e
ri
-r
e
c
ta
lo
r
p
e
ri
-a
n
a
ls
w
a
b
s
.
†
H
o
s
p
it
a
l,
lo
n
g
-t
e
rm
c
a
re
fa
c
ili
ty
,
n
u
rs
in
g
h
o
m
e
s
,
m
a
te
rn
it
y
w
a
rd
s
.
ϕ
In
fo
rm
a
ti
o
n
o
b
ta
in
e
d
fr
o
m
th
e
a
u
th
o
r.
P
h
e
n
o
ty
p
ic
id
e
n
ti
fic
a
ti
o
n
:
c
u
lt
u
re
c
h
a
ra
c
te
ri
s
ti
c
s
o
n
m
a
n
n
it
o
ls
a
lt
a
g
a
r,
B
a
ir
d
-P
a
rk
e
r
a
g
a
r,
Tr
ip
ti
c
a
s
e
s
o
y
a
g
a
r,
C
h
a
p
m
a
n
a
g
a
r,
S
ta
p
h
yl
o
c
o
c
c
u
s
m
e
d
iu
m
1
1
0
,
p
o
s
it
iv
e
re
s
u
lt
s
fo
r
G
ra
m
s
ta
in
,
c
a
ta
la
s
e
,
c
o
a
g
u
la
s
e
a
n
d
D
N
a
s
e
Te
s
ts
.
a
g
r,
A
c
c
e
s
s
o
ry
g
e
n
e
re
g
u
la
to
r;
A
U
R
,
A
u
re
o
ly
s
is
n
;
B
A
P,
b
io
fil
m
-a
s
s
o
c
ia
te
d
p
ro
te
in
;
C
N
A
,
c
o
lla
g
e
n
-b
in
d
in
g
p
ro
te
in
;
C
O
P
D
,
c
h
ro
n
ic
o
b
s
tr
u
c
ti
ve
p
u
lm
o
n
a
ry
d
is
o
rd
e
r;
E
T,
E
xf
o
lia
ti
ve
to
xi
n
s
;
M
LV
A
,
M
u
lt
ip
le
-l
o
c
u
s
va
ri
a
b
le
-n
u
m
b
e
r
ta
n
d
e
m
re
p
e
a
t
a
n
a
ly
s
is
;
M
R
S
A
,
m
e
th
ic
ill
in
re
s
is
ta
n
t
S
ta
p
h
yl
o
c
o
c
c
u
s
a
u
re
u
s
;
N
IC
U
,
N
e
o
n
a
ta
li
n
te
n
s
iv
e
c
a
re
u
n
it
;
N
R
,
N
o
t
re
p
o
rt
e
d
;
N
P,
N
o
t
p
e
rf
o
rm
e
d
;
N
A
,
N
o
t
a
p
p
lic
a
b
le
;
P
F
G
E
:
p
u
ls
e
d
-fi
e
ld
g
e
le
le
c
tr
o
p
h
o
re
s
is
;
P
V
L
,
P
a
n
to
n
-V
a
le
n
ti
n
e
L
e
u
ko
c
id
in
;
S
C
C
m
e
c
,
s
ta
p
h
yl
o
c
o
c
c
a
lc
a
s
s
e
tt
e
c
h
ro
m
o
s
o
m
e
m
e
c
;
S
E
,
S
ta
p
h
yl
o
c
o
c
c
a
le
n
te
ro
to
xi
n
s
;
s
p
a
,
S
ta
p
h
yl
o
c
o
c
c
u
s
a
u
re
u
s
p
ro
te
in
A
;
T
S
S
T,
To
xi
c
s
h
o
c
k
s
yn
d
ro
m
e
to
xi
n
;
V
R
E
,
V
a
n
c
o
m
yc
in
-r
e
s
is
ta
n
c
e
e
n
te
ro
c
o
c
c
i.
Frontiers in Microbiology | www.frontiersin.org 12 May 2016 | Volume 7 | Article 449
Claassen-Weitz et al. Fecal Carriage of Staphylococcus aureus
FIGURE 2 | Bias assessment (Funnel) plot for studies assessing
Staphylococcus aureus fecal carriage rates.
FIGURE 3 | Bias assessment (Funnel) plot for studies assessing
Methicillin susceptible Staphylococcus aureus fecal carriage rates.
FIGURE 4 | Bias assessment (Funnel) plot for studies assessing
Methicillin resistant Staphylococcus aureus fecal carriage rates.
screened with 32 different antibiotics across the respective studies
using disk diffusion, agar dilution, or the Vitek Legacy System.
The use of published guidelines for susceptibility testing were
reported by six of the eight studies (Table 5). Susceptibility
testing to erythromycin was performed most frequently (88%;
7/8), followed by chloramphenicol, clindamycin, ciprofloxacin,
gentamicin, penicillin and vancomycin (75%; 6/8) (Table 5).
Vancomycin intermediate or resistant S. aureus (VISA/VRSA)
were not identified in five of the six studies that screened for
vancomycin resistance (Table 5). Only the study by Onanuga
and Temedie (2011) reported fecal VRSA carriage of 37%
(14/38).
Genotyping of S. aureus Isolated from
Fecal Specimens
Techniques used to genotype S. aureus isolated from fecal
specimens included multiple-locus variable-number tandem
repeat analysis (MLVA), pulsed-field gel electrophoresis
(PFGE), random amplified polymorphic DNA (RAPD) analysis,
staphylococcal cassette chromosome mec (SCCmec), accessory
gene regulator (agr) and Staphylococcus aureus protein A (spa)
typing (Tables 3, 4). Genotyping was performed in slightly more
reports from the healthcare setting (67%; 8/12) compared to the
community (58%; 11/19). Gel-based methods (PFGE, RAPD and
MLVA) were employed in 58% (7/12) and 42% (8/19) of studies in
the healthcare and community settings, respectively. In addition,
similar rates (26% vs. 25%) in the use of sequence-based methods
(spa typing, SCCmec typing and MLST) for genotyping of S.
aureus strains were reported from community and healthcare
settings. Only a single study conducted in a developing country
(Jordan) performed genotyping of the S. aureus strains (Shehabi
et al., 2013).
Assessment of the Detection of S. aureus
Virulence Genes
Virulence genes screened included the aureolysin enzyme,
biofilm-associated protein, collagen-binding protein, exfoliative
toxins (ETs), staphylococcal enterotoxins (SEs), toxic shock
syndrome toxin (TSST), and Panton-Valentine leukocidin (PVL)
(Tables 3, 4). More community–based investigations screened
for S. aureus virulence genes compared to reports from the
healthcare setting. Thus, 53% (10/19), 37% (7/19), and 37%
(7/19) of studies conducted in the community setting reported
on TSSTs, SEs, ETs, respectively, using PCR, reverse passive latex
agglutination tests or enzyme-linked immunosorbent assays.
Approximately one third of the studies conducted in the
community setting (6/19) reported on PCR detection of the PVL
genes. In studies conducted in the healthcare setting; 8% (1/12),
25% (3/12.), 8% (1/12), and 25% (3/12) reported on TSSTs, SEs,
ETs, and PVL, respectively.
S. aureus and MRSA Fecal Carriage as
Risk Factors for Disease Development
Two studies included in this review identified enterotoxin
producing S. aureus strains from fecal specimens of patients
with diarrhea (Efuntoye and Adetosoye, 2003; Flemming and
Ackermann, 2007). Another study reported that all patients
colonized with MRSA in both the nares and rectum (8/8)
developed an infection (Srinivasan et al., 2010). In addition, two
of the nine patients, colonized with MRSA in the rectum only,
were concurrently or subsequently infected. Spa typing on a
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FIGURE 5 | Meta-analysis of proportions on S. aureus fecal carriage rates. *, Community setting; +, Healthcare setting; H, Healthy participants; O,
Outpatients; I, Inpatients; HP, Healthcare personnel.
FIGURE 6 | Meta-analyses of proportions on Methicillin susceptible Staphylococcus aureus fecal carriage rates. Pooled random-effects estimate of MSSA
fecal carriage within the community and healthcare setting. *, Community setting; +, Healthcare setting; H, Healthy participants; HP, Healthcare personnel.
subset of colonizing isolates from the nares and rectum noted
that the majority (69%; 9/13) were clonally related to infecting
isolates (Srinivasan et al., 2010). In support of the potential
of fecal carriage for infection, it has also been shown that S.
aureus detection occurs more frequently from rectal specimens
of children with skin and soft tissue abscesses (47%; 28/60)
compared with the control group (1%; 1/90) (P= 0.0001) (Faden
et al., 2010).
DISCUSSION
Our results clearly showed that fecal S. aureus carriage from
healthy infants is high during the first year of life. Specifically,
S. aureus fecal carriage rates increased during the first 8 weeks
of life followed by a gradual decrease towards 1 year of life.
The reasons for this abrupt increase in fecal carriage very
early in life (especially from healthy infants) is not yet clear,
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FIGURE 7 | Meta-analyses of proportions on Methicillin resistant Staphylococcus aureus fecal carriage rates. Pooled random effects estimate of MRSA
fecal carriage within community and healthcare settings. *, Community setting; +, Healthcare setting; H, Healthy participants; HP, Healthcare personnel.
FIGURE 8 | Longitudinal S. aureus fecal carriage rates during the first year of life. The lines in color indicated fecal carriage rates (%) at each of the
time-points measured by the respective studies. The different cohorts are shown by different symbols at each of the time-points studied. The black broken line is the
average fecal S. aureus carriage rate calculated from all longitudinal studies at the respective time-points under study.
however a potential explanation may be early life care-giving
practices, particularly breastfeeding. For example, colostrum
contains the highest levels of human milk oligosaccharides
(HMOs) (Bode, 2012), which have been suggested to stimulate
S. aureus growth (Hunt et al., 2012). Moreover, S. aureus strains
may be transmitted from parents via skin contact (Lindberg et al.,
2004a) or from the mother via breastfeeding (Kawada et al.,
2003; Lindberg et al., 2004a; Benito et al., 2015). Furthermore,
staphylococci from the maternal GIT or skin surrounding the
areola may be transferred to breast milk during lactation (Thum
et al., 2012; Fernández et al., 2013). Higher S. aureus fecal carriage
rates have also been noted from breast-fed in comparison to
formula-fed ormixed-fed infants (González et al., 2013; Salminen
et al., 2015). The observed change in the dynamics of S. aureus
fecal carriage after 8 weeks of lifemay be explained by the increase
in anaerobic bacteria from around 1 week of life (Bezirtzoglou,
1997; Adlerberth et al., 2006; Adlerberth and Wold, 2009; Jost
et al., 2012), as well as the introduction of formula feeding
(González et al., 2013) and solid foods (Bergström et al., 2014;
Voreades et al., 2014). Infant fecal bacterial profiles have also
been shown to change during the course of the lactation period
(Cabrera-Rubio et al., 2012; González et al., 2013).
This systematic review does not only provide insight into the
dynamics of fecal S. aureus carriage rates during the first year of
life; but also highlights that S. aureus and MRSA fecal carriage
is a potential risk factor for subsequent infections. Vancomycin is
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regarded as one of the drugs of choice for MRSA infections (Tarai
et al., 2013); however the emergence of vancomycin resistant
S. aureus (VRSA) poses yet another threat to infection control
(Hiramatsu, 1998; Spagnolo et al., 2014). The intestinal tract, in
particular, may be a key potential reservoir for the emergence and
transmission of VRSA isolates due to the intestinal coexistence
(Ray et al., 2003), and potential transfer of the vanA gene from
VRE to MRSA (Courvalin, 2006). Although, 23% of the studies
included in this review screened for fecal carriage of VRSA
within community and healthcare settings (Domínguez et al.,
2002; Lindberg et al., 2004b; Srinivasan et al., 2010; Onanuga and
Temedie, 2011; Benito et al., 2013, 2015); only a single study,
performed in Nigeria, reported VRSA fecal carriage (Onanuga
and Temedie, 2011). It is noteworthy, however, that this finding
should be interpreted with caution as the disk diffusion method
was used to screen for vancomycin resistance at 30 µg/ml, which
is not recommended by the CLSI guidelines (Clinical Laboratory
Standards Institute, 2012).
Healthcare associated fecal screening for S. aureus and MRSA
is of key importance in infection control (Campillo et al.,
2001; Ray et al., 2003; Bhalla et al., 2007). For example, it
has been shown that select staphylococcal enterotoxins (SEs)
may contribute to the colonizing success of S. aureus strains
in the GIT (Nowrouzian et al., 2011), which could potentially
facilitate in its transmission. Moreover, S. aureus and MRSA
fecal carriage may complicate de-colonization, with a potential to
contribute to infections within the healthcare setting (Campillo
et al., 2001; Dupeyron et al., 2002; Ray et al., 2003; Srinivasan
et al., 2010). To prevent nosocomial transmission and infection,
two recent studies (Roth et al., 2016; Senn et al., 2016) have
also highlighted the importance of screening for S. aureus fecal
carriage on admission in the following risk groups: patients
admitted to surgery or intensive care units with a history of
MRSA colonization or infection; hospitalization during the past
year; or direct transfer from another healthcare facility. Only a
single study was considered eligible for inclusion in our meta-
analyses of the proportions on MSSA and MRSA fecal carriage
within the healthcare setting. Therefore we could not determine
the fecal carriage rate for MSSA or MRSA within this setting.
A major limitation in this systematic review is the poor
study design and limited data available from studies assessing
the fecal carriage rates of S. aureus and MRSA. For example, a
large proportion of potentially eligible articles were excluded due
to the lack of information regarding participants’ contact with
healthcare facilities as well as the duration of hospital admission
prior to S. aureus and MRSA screening. This information is
essential in comparing fecal carriage rates from community and
healthcare settings. Furthermore, a number of studies could
not be included in calculating the pooled estimates for MSSA
and MRSA fecal carriage (from both community and healthcare
settings) due to the lack of molecular techniques incorporated to
confirm MRSA carriage. On the other hand, the extent in which
our observations could have changed if unavailable articles were
included is unclear. However, based on the rigorous appraisal
of various studies in this systematic review, we conclude that
the excluded articles are not likely to impact significantly on
observations presented in the manuscript. In addition, more
studies from both developed and developing countries are needed
in order to determine S. aureus and MRSA fecal carriage and
transmission within and between the community and healthcare
settings. In support of this, rural areas and low socioeconomic
status have been shown to contribute to higher fecal transmission
rates of S. aureus and MRSA (Vale and Vítor, 2010). Finally,
there is the need for more sequence-based genotyping data on
S. aureus andMRSA fecal carriage as the majority of studies from
developed countries made use of gel-based methods which are
not ideal when comparing isolates on a global level.
CONCLUSION
S. aureus, MSSA and MRSA fecal carriage rates within both
the community and healthcare setting are not negligible
and estimated at 26, 86, and 10%, respectively. Therefore,
preventative strategies which include fecal S. aureus screening
of high risk patients are necessary for infection control within
these settings. More studies are needed to determine the role of
fecal S. aureus carriage as a risk factor for disease development;
as well as fecal carriage rates of MSSA, MRSA, and VRSA from
both community and healthcare settings. Furthermore, well-
structured research should be conducted and sequence-based
genotyping techniques should be employed. The latter will allow
for comparison of isolates on a global level in both developing
and developed countries.
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